COVID-19 mRNA revaccination may be considered for individuals with chest pain not meeting criteria for myocarditis but caution is warranted in adults with prior confirmed myopericarditis post-COVID-19 mRNA vaccination.
No takes yet. Share an insight, caveat, or question.
Piché-Renaud et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: